Elizabeth Lash

Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment

O. Igoucheva, Takami Sato, M. Terai, 2017, Oncotarget.

Radiation Protection of the Gastrointestinal Tract and Growth Inhibition of Prostate Cancer Xenografts by a Single Compound

K. Ward, A. Dicker, U. Rodeck, 2014, Molecular Cancer Therapeutics.

The Triterpenoid RTA 408 is a Robust Mitigator of Hematopoietic Acute Radiation Syndrome in Mice

U. Rodeck, C. Guha, W. Fleming, 2015, Radiation research.